Why have this procedure done in China specifically?

China offers the same FDA/EMA-approved biologics (secukinumab, ixekizumab) at approximately 40–60% lower cost than in the US or Europe, with the full 12-week induction priced around $3,200. Chinese dermatology centers are equipped with modern facilities and high patient volumes, ensuring extensive clinical experience with these therapies. Additionally, streamlined medical tourism services provide coordinated care, translation, and follow-up support.